Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
08HH:FRA
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
2,03 €
-1,27%
(-0,026) 1D
4-май, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 08HH...
Open
2,04 €
High
2,04 €
Low
2,03 €
Mkt. cap
70,89 млд
Avg. vol.
471,00
Volume
1,00 миң
52-wk high
3,22 €
52-wk low
1,51 €
No. of employees
41 миң
News stories
From sources across the web
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40,6 миң
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitefosunpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
10,09 млд
9,88 млд
12,27 млд
10,07 млд
Cost of goods sold
5,22 млд
5,08 млд
5,65 млд
5,07 млд
Cost of revenue
5,22 млд
5,08 млд
5,65 млд
5,07 млд
Research and development expenses
979,21 млн
1,01 млд
1,28 млд
896,79 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,14 млд
3,10 млд
4,44 млд
3,27 млд
Operating expense
4,19 млд
4,04 млд
5,92 млд
4,19 млд
Total operating expenses
9,41 млд
9,12 млд
11,57 млд
9,26 млд
Operating income
685,50 млн
758,38 млн
699,05 млн
813,78 млн
Other non operating income
-4,87 млн
-116,85 млн
107,33 млн
2,03 млн
EBT including unusual items
1,37 млд
1,12 млд
1,27 млд
1,36 млд
EBT excluding unusual items
1,16 млд
1,49 млд
1,10 млд
1,21 млд
Income tax expense
212,30 млн
162,98 млн
82,80 млн
277,92 млн
Effective tax rate
15,49%
14,57%
6,50%
20,47%
Other operating expenses
49,69 млн
-92,19 млн
117,57 млн
19,04 млн
Net income
937,21 млн
821,33 млн
847,27 млн
870,83 млн
Net profit margin
9,28%
8,31%
6,91%
8,64%
Earnings per share
-
-
-
-
Interest and investment income
925,83 млн
1,05 млд
732,13 млн
689,67 млн
Interest expense
-323,25 млн
-321,25 млн
-291,32 млн
-296,51 млн
Net interest expenses
602,58 млн
727,28 млн
440,80 млн
393,16 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,38 млд
1,39 млд
1,47 млд
1,59 млд
Gain or loss from assets sale
-2,12 млн
2,12 млн
-69,35 млн
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer